01 5Lokelma
Sodium Zirconium Cyclosilicate
Main Therapeutic Indication : Cardiovascular Diseases
Currency : USD
2020 Revenue in Millions : 76
2019 Revenue in Millions : 14
Growth (%) : 443
Sodium Zirconium Cyclosilicate
Main Therapeutic Indication : Cardiovascular Diseases
Currency : USD
2021 Revenue in Millions : 175
2020 Revenue in Millions : 76
Growth (%) : 130
Sodium Zirconium Cyclosilicate
Main Therapeutic Indication : Cardiology/Vascular Diseases
Currency : USD
2022 Revenue in Millions : 289
2021 Revenue in Millions : 175
Growth (%) : 65
Sodium Zirconium Cyclosilicate
Main Therapeutic Indication : Cardiology/Vascular Diseases
Currency : USD
2023 Revenue in Millions : 412
2022 Revenue in Millions : 289
Growth (%) : 43
Sodium Zirconium Cyclosilicate
Main Therapeutic Indication : Cardiovascular Diseases
Currency : USD
2019 Revenue in Millions : 14
2018 Revenue in Millions : 0
Growth (%) : New launch
LOOKING FOR A SUPPLIER?
